QIETIFY
Dead / Abandoned — Abandoned — no statement of use filed (as of 13 Feb 2023)
What this means for you
This application is over — abandoned 13 Feb 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88519283
- Mark type
- Stylized text
- Filed
- 17 Jul 2019
- Published for opposition
- 12 Nov 2019
- Abandoned
- 13 Feb 2023
- Attorney of record
- Sarah Anne Keefe
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of human and veterinary diseases and disorders, namely, addiction, autism, auditory diseases and disorders, autoimmune diseases and disorders, anxiety, bone diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, central nervous system diseases and disorders, cognitive diseases and disorders, dermatological diseases and disorders, diabetic diseases and disorders, endocrine diseases and disorders, fragile x syndrome, gastroenterological diseases and disorders, genetic diseases and disorders, genitourinary diseases and disorders, hepatological diseases and disorders, hormonal diseases and disorders, infectious diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, metabolic diseases and disorders, movement diseases and disorders, muscular diseases and disorders, musculoskeletal diseases and disorders, neurodegenerative diseases and disorders, neurological diseases and disorders, oncological diseases and disorders, ophthalmic diseases and disorders, pain, post-traumatic stress, pulmonary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, rheumatological diseases and disorders, psychiatric diseases and disorders, seizure diseases and disorders, sexual dysfunction, speech diseases and disorders, and viral diseases and disorders
Owner
- Zynerba Pharmaceuticals, Inc., Devon, PA, US
- Zynerba Pharmaceuticals, Inc., Devon, PA, US
Prosecution history
- 13 Feb 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 13 Feb 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 09 Jul 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Jul 2022 — SOU EXTENSION 5 GRANTED
- 24 Jun 2022 — SOU EXTENSION 5 FILED
- 08 Jul 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 24 Jun 2022 — SOU TEAS EXTENSION RECEIVED
- 08 Jan 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Jan 2022 — SOU EXTENSION 4 GRANTED
- 06 Jan 2022 — SOU EXTENSION 4 FILED
- 06 Jan 2022 — SOU TEAS EXTENSION RECEIVED
- 02 Jul 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Jun 2021 — SOU EXTENSION 3 GRANTED
- 30 Jun 2021 — SOU EXTENSION 3 FILED
- 30 Jun 2021 — SOU TEAS EXTENSION RECEIVED